UBS reduces its stake in Green Valley Pharmaceutical (02186.HK) by 26.125 million shares at a price of approximately HK$3.74 per share.

According to the Smart Financial APP, the latest data from the Hong Kong Stock Exchange showed that on June 16, UBS reduced its holdings of Liuye Pharmaceuticals (02186.HK) by 26.125 million shares, with a price of 3.7415 Hong Kong dollars per share, for a total amount of approximately 97.7467 million Hong Kong dollars. After the reduction, the new number of shares held is approximately 487 million shares, and the latest shareholding ratio is 12.94%.